CURRENT MEDICATIONS OVERVIEW,,
MEDICATION,GENE(S),PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST
"Sertraline",CYP2C19,"Minor – result should be considered as may affect medicationresponse"
"Codeine (componentof Acetaminophen-Caffeine-Codeine)","CYP2D6OPRM1",Usual prescribing considerations apply
"Dexamphetamine",CYP2D6,Usual prescribing considerations apply
"Diclofenac",CYP2C9,Usual prescribing considerations apply
"Propranolol","CYP1A2CYP2D6",Usual prescribing considerations apply
MEDICATIONS THAT DO NOT HAVE PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST,,
"gabapentin, oestrogen (Premarin Tablets), zopiclone, dimenhydrinate (Anti-Nauseant), acetaminophen(component of Acetaminophen-Caffeine-Codeine), caffeine (component of Acetaminophen-Caffeine-Codeine)",,
MEDICATIONS WITH MAJOR PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
Antiplatelet drugs,Clopidogrel,CYP2C19,Reduced / inadequate response,CPIC4
MEDICATIONS WITH MINOR PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
Anticoagulants,Acenocoumarol,"VKORC1CYP2C9","Increased acenocoumarolsensitivity",
"",Warfarin,"VKORC1CYP2C9",Increased warfarin sensitivity,FDA5
"Antidepressants -other",Moclobemide,CYP2C19,Adverse effects,-
"Antidepressants -SSRIs",Citalopram,CYP2C19,Adverse effects,CPIC1
"",Escitalopram,CYP2C19,Adverse effects,CPIC1
"",Sertraline,CYP2C19,Adverse effects,CPIC1
"Antidepressants -tricyclicantidepressants",Amitriptyline,"CYP2D6CYP2C19",Adverse effects,CPIC6
"",Clomipramine,"CYP2D6CYP2C19",Adverse effects,CPIC6
"",Doxepin,"CYP2D6CYP2C19",Adverse effects,CPIC6
"",Imipramine,"CYP2D6CYP2C19",Adverse effects,CPIC6
Antifungals - Azoles,Voriconazole,CYP2C19,"Increased therapeutic and/oradverse effects",CPIC7
Antipsychotics,Quetiapine,CYP3A4,Adverse effects,-
Benzodiazepines,Clobazam,CYP2C19,Adverse effects,-
"",Diazepam,CYP2C19,Adverse effects,-
Miscellaneous,Cyclophosphamide,CYP2C19,Reduced / inadequate response,-
"",Proguanil,CYP2C19,Reduced / inadequate response,-
Opioid Analgesics,Morphine,OPRM1,"Associated with reducedresponse to morphine",-
"Proton pumpinhibitors",Dexlansoprazole,CYP2C19,Altered response,FDA8
"",Esomeprazole,CYP2C19,Altered response,-
"",Lansoprazole,CYP2C19,Altered response,-
"",Omeprazole,CYP2C19,Altered response,-
"",Pantoprazole,CYP2C19,Altered response,-
Statins,Atorvastatin,"SLCO1B1CYP3A4","Increased therapeutic and/oradverse effects",-
Simvastatin,"SLCO1B1CYP3A4","Increased therapeutic andadverse effects",CPIC9,
MEDICATIONS WITH USUAL PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"ADHD -miscellaneous agents",Atomoxetine,CYP2D6,"No altered effect predicted bygenotype",-
"Angiotensin receptorblockers",Irbesartan,CYP2C9,"No altered effect predicted bygenotype",-
"",Losartan,CYP2C9,"No altered effect predicted bygenotype",-
Antiarrhythmics,Flecainide,CYP2D6,"No altered effect predicted bygenotype",-
"",Propafenone,CYP2D6,"No altered effect predicted bygenotype",-
"Anticholinergics(genitourinary)",Darifenacin,CYP2D6,"No altered effect predicted bygenotype",-
MEDICATIONS WITH USUAL PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"",Fesoterodine,CYP2D6,"No altered effect predicted bygenotype",-
"",Tolterodine,CYP2D6,"No altered effect predicted bygenotype",-
Anticholinesterases,Donepezil,CYP2D6,"No altered effect predicted bygenotype",-
"",Galantamine,CYP2D6,"No altered effect predicted bygenotype",-
"Antidepressants -other",Mirtazapine,"CYP2D6CYP1A2","No altered effect predicted bygenotype",-
"",Vortioxetine,CYP2D6,"No altered effect predicted bygenotype",-
"Antidepressants -serotoninnoradrenalinereuptake inhibitors",Duloxetine,"CYP2D6CYP1A2","No altered effect predicted bygenotype",-
"",Venlafaxine,CYP2D6,"No altered effect predicted bygenotype",DPWG10
"Antidepressants -SSRIs",Fluoxetine,"CYP2D6CYP2C9","No altered effect predicted bygenotype",-
"",Fluvoxamine,"CYP2D6CYP1A2","No altered effect predicted bygenotype",CPIC1
"",Paroxetine,CYP2D6,"No altered effect predicted bygenotype",CPIC1
"Antidepressants -tricyclicantidepressants",Desipramine,CYP2D6,"No altered effect predicted bygenotype",CPIC6
"",Nortriptyline,CYP2D6,"No altered effect predicted bygenotype",CPIC6
Antidiabetics,Gliclazide,"CYP2C9CYP2C19","No altered effect predicted bygenotype",-
"",Glimepiride,CYP2C9,"No altered effect predicted bygenotype",-
"",Glyburide,CYP2C9,"No altered effect predicted bygenotype",-
Antiemetics,Metoclopramide,CYP2D6,"No altered effect predicted bygenotype",-
"",Ondansetron,CYP2D6,"No altered effect predicted bygenotype",CPIC11
Antiepileptics,Phenytoin,CYP2C9,"No altered effect predicted bygenotype",CPIC12
Antihistamines,Chlorpheniramine,CYP2D6,"No altered effect predicted bygenotype",-
"",Dexchlorpheniramine,CYP2D6,"No altered effect predicted bygenotype",-
"",Promethazine,CYP2D6,"No altered effect predicted bygenotype",-
Antipsychotics,Aripiprazole,CYP2D6,"No altered effect predicted bygenotype",-
Brexpiprazole,CYP2D6,"No altered effect predicted bygenotype",-,
Chlorpromazine,CYP2D6,"No altered effect predicted bygenotype",-,
Clozapine,CYP1A2,"No altered effect predicted bygenotype",-,
Haloperidol,CYP2D6,"No altered effect predicted bygenotype",-,
MEDICATIONS WITH USUAL PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"",Olanzapine,CYP1A2,"No altered effect predicted bygenotype",-
"",Pimozide,CYP2D6,"No altered effect predicted bygenotype",
"",Risperidone,CYP2D6,"No altered effect predicted bygenotype",-
"",Zuclopenthixol,CYP2D6,"No altered effect predicted bygenotype",-
Antitussives,Dextromethorphan,CYP2D6,"No altered effect predicted bygenotype",-
Beta blockers,Carvedilol,CYP2D6,"No altered effect predicted bygenotype",-
"",Metoprolol,CYP2D6,"No altered effect predicted bygenotype",-
"",Nebivolol,CYP2D6,"No altered effect predicted bygenotype",-
"",Propranolol,"CYP2D6CYP1A2","No altered effect predicted bygenotype",-
Calcineurin inhibitors,Tacrolimus,CYP3A5,"No altered effect predicted bygenotype",CPIC13
"Glaucoma - ocularpreparations",Timolol,CYP2D6,"No altered effect predicted bygenotype",-
Hypnotics,Melatonin,CYP1A2,"No altered effect predicted bygenotype",-
"Immunomodulatorsand antineoplastics",Tamoxifen,CYP2D6,"No altered effect predicted bygenotype",CPIC14
Miscellaneous,Atazanavir,CYP3A5,"No altered effect predicted bygenotype",-
"",Eliglustat,CYP2D6,"No altered effect predicted bygenotype",TGA15
"",Naltrexone,OPRM1,"No altered effect predicted bygenotype for naltrexone",
Neurological drugs,Tetrabenazine,CYP2D6,"No altered effect predicted bygenotype",FDA16
NSAIDs,Celecoxib,CYP2C9,"No altered effect predicted bygenotype",-
"",Diclofenac,CYP2C9,"No altered effect predicted bygenotype",-
"",Flurbiprofen,CYP2C9,"No altered effect predicted bygenotype",-
"",Ibuprofen,CYP2C9,"No altered effect predicted bygenotype",-
"",Indomethacin,CYP2C9,"No altered effect predicted bygenotype",-
"",Mefenamic Acid,CYP2C9,"No altered effect predicted bygenotype",-
"",Meloxicam,CYP2C9,"No altered effect predicted bygenotype",-
"",Piroxicam,CYP2C9,"No altered effect predicted bygenotype",-
Opioid Analgesics,Codeine,"CYP2D6OPRM1","Associated with reducedsensitivity to codeine",CPIC2
Hydrocodone,CYP2D6,"No altered effect predicted bygenotype",,
MEDICATIONS WITH USUAL PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"",Oxycodone,CYP2D6,"No altered effect predicted bygenotype",-
"",Tramadol,CYP2D6,"No altered effect predicted bygenotype",-
"Proton pumpinhibitors",Rabeprazole,CYP2C19,"No altered effect predicted bygenotype",-
Psychostimulants,Dextroamphetamine,CYP2D6,"No altered effect predicted bygenotype",-
"",Lisdexamfetamine,CYP2D6,"No altered effect predicted bygenotype",-
Statins,Fluvastatin,"SLCO1B1CYP2C9","No altered effect predicted bygenotype",-
Pravastatin,SLCO1B1,"No altered effect predicted bygenotype",-,
Rosuvastatin,SLCO1B1,"No altered effect predicted bygenotype",-,
